Protalix BioTherapeutics, Inc.
Asset & Liabilities Breakdown
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
FY2012
FY2011
FY2010
Asset Breakdown FY2023
Total Assets: $84.4M
Liabilities Breakdown FY2023
Total Liabilities: $50.9M
Asset Breakdown
Total Assets: $84.4M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $23.6M | 28.0% |
| Accounts Receivable | $5.3M | 6.2% |
| Inventory | $19.0M | 22.6% |
| Property, Plant & Equipment | $5.0M | 5.9% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $0 | 0.0% |
| Other Assets | $31.5M | 37.3% |
Liabilities Breakdown
Total Liabilities: $50.9M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $19.6M | 38.4% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $31.3M | 61.6% |